Published in Gastroenterology on December 01, 2004
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) (2008) 5.82
Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45
Overuse of screening colonoscopy in the Medicare population. Arch Intern Med (2011) 3.08
Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol (2008) 2.14
Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev (2009) 2.10
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer (2009) 1.88
Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med (2012) 1.54
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) (2012) 1.48
Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med (2009) 1.41
Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J Natl Med Assoc (2007) 1.27
As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther (2008) 1.25
Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region. JAMA Intern Med (2013) 1.22
Improving rates for screening colonoscopy: Analysis of the health information national trends survey (HINTS I) data. Surg Endosc (2007) 1.22
Many patients who undergo surgery for colorectal cancer receive surveillance colonoscopies earlier than recommended by guidelines. Clin Gastroenterol Hepatol (2012) 1.22
Challenges in the management of positive fecal occult blood tests. J Gen Intern Med (2009) 1.17
Would you recommend screening colonoscopy for the very elderly? Intest Res (2014) 1.15
Community contextual predictors of endoscopic colorectal cancer screening in the USA: spatial multilevel regression analysis. Int J Health Geogr (2010) 1.15
Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol (2005) 1.09
Colon cancer knowledge and attitudes in an immigrant Haitian community. J Immigr Minor Health (2008) 1.06
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. JAMA (2017) 1.05
Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. Clin Gastroenterol Hepatol (2012) 1.01
Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy. World J Gastroenterol (2006) 1.01
Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev Res (Phila) (2012) 0.99
Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract (2012) 0.98
Characterization of forces applied by endoscopists during colonoscopy by using a wireless colonoscopy force monitor. Gastrointest Endosc (2009) 0.96
Predictors of endoscopic colorectal cancer screening over time in 11 states. Cancer Causes Control (2009) 0.93
Balanced propofol sedation administered by nonanesthesiologists: The first Italian experience. World J Gastroenterol (2011) 0.92
Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study. BMC Gastroenterol (2012) 0.91
Clinical validation of the European Panel on the Appropriateness of Gastrointestinal Endoscopy (EPAGE) II criteria in an open-access unit: a prospective study. Endoscopy (2011) 0.91
The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterol (2011) 0.91
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer (2015) 0.90
Colonoscopy capacity: Can we build it? Will they come? Gastroenterology (2004) 0.89
Intraurban influences on physician colorectal cancer screening practices. J Natl Med Assoc (2007) 0.89
Quality and safety of screening colonoscopies performed by primary care physicians with standby specialist support. Med Care (2010) 0.89
Implications of new colorectal cancer screening technologies for primary care practice. Med Care (2008) 0.87
Association of local capacity for endoscopy with individual use of colorectal cancer screening and stage at diagnosis. Cancer (2010) 0.87
Automated volumetric analysis for comparison of oral sulfate solution (SUPREP) with established cathartic agents at CT colonography. Abdom Imaging (2015) 0.86
Do colorectal cancer patients understand that their family is at risk? Dig Dis Sci (2009) 0.84
Comparative effectiveness of i-SCAN™ and high-definition white light characterizing small colonic polyps. World J Gastroenterol (2012) 0.83
Role of high definition colonoscopy in colorectal adenomatous polyp detection. World J Gastroenterol (2011) 0.81
Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81
Dynamic tumor growth patterns in a novel murine model of colorectal cancer. Cancer Prev Res (Phila) (2013) 0.81
On attitudes about colorectal cancer screening among gastrointestinal specialists and general practitioners in the Netherlands. World J Gastroenterol (2006) 0.80
Surgeon-initiated screening colonoscopy program based on SAGES and ASCRS recommendations in a general surgery practice. Surg Endosc (2006) 0.80
Splenic rupture as a complication of colonoscopy: report of a case. Surg Today (2009) 0.79
Rate and yield of repeat upper endoscopy in patients with dyspepsia. World J Gastroenterol (2010) 0.79
Colon cancer screening update and management of the malignant polyp. Clin Colon Rectal Surg (2005) 0.78
Colonoscopy screening rates among patients of colonoscopy-trained African American primary care physicians. Cancer (2011) 0.78
Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut (2016) 0.77
Predictors of guideline concordance for surveillance colonoscopy recommendations in patients at a safety-net health system. Cancer Causes Control (2015) 0.77
Colorectal Cancer Screening Based on Age and Gender: A Cost-Effectiveness Analysis. Medicine (Baltimore) (2016) 0.75
Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut (2016) 0.75
Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008-2012. Prev Chronic Dis (2014) 0.75
Test-positive rate at CT colonography is increased by rectal bleeding and/or unexplained weight loss, unlike other common gastrointestinal symptoms. Eur J Radiol Open (2015) 0.75
CT colonography: Friend or foe of practicing endoscopists. World J Gastrointest Endosc (2009) 0.75
Can optical diagnosis of small colon polyps be accurate? Comparing standard scope without narrow banding to high definition scope with narrow banding. World J Gastroenterol (2016) 0.75
Use of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study. BMJ Open Gastroenterol (2015) 0.75
Application of proteomics to cancer early detection. Cancer J (2011) 0.75
Physician perceptions on colonoscopy quality: results of a national survey of gastroenterologists. Gastroenterol Res Pract (2014) 0.75
Validation of a risk prediction score for proximal neoplasia in colorectal cancer screening: a prospective colonoscopy study. Sci Rep (2016) 0.75
A risk profile for advanced proximal neoplasms on diagnostic colonoscopy. Dig Dis Sci (2008) 0.75
Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med (2006) 5.10
How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology (2004) 4.69
Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 3.64
Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care (2005) 3.53
Can we predict the outcomes of national colorectal cancer screening and can predictions help us plan? Gastroenterology (2005) 2.91
Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med (2009) 2.84
Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev (2011) 2.62
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 2.31
The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms. Am J Prev Med (2010) 2.28
Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev (2004) 2.26
Smokefree policies to reduce tobacco use. A systematic review. Am J Prev Med (2010) 2.07
Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control (2006) 2.02
A systematic review of selected interventions for worksite health promotion. The assessment of health risks with feedback. Am J Prev Med (2010) 2.02
Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Prev Chronic Dis (2006) 1.79
Effects of dram shop liability and enhanced overservice law enforcement initiatives on excessive alcohol consumption and related harms: Two community guide systematic reviews. Am J Prev Med (2011) 1.70
Economic value of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity a community guide systematic review. Am J Prev Med (2011) 1.68
Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis (2006) 1.57
Market for colorectal cancer screening by endoscopy in the United States. Am J Prev Med (2005) 1.55
The effectiveness of interventions to reduce psychological harm from traumatic events among children and adolescents: a systematic review. Am J Prev Med (2008) 1.54
Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc (2007) 1.49
The acute medical care costs of fall-related injuries among the U.S. older adults. Injury (2005) 1.42
Out-of-School-Time Academic Programs to Improve School Achievement: A Community Guide Health Equity Systematic Review. J Public Health Manag Pract (2016) 1.39
Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics (2008) 1.35
Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract (2002) 1.31
Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale? Med Decis Making (2002) 1.28
Effectiveness of multicomponent programs with community mobilization for reducing alcohol-impaired driving. Am J Prev Med (2009) 1.27
Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 1.22
Economics of collaborative care for management of depressive disorders: a community guide systematic review. Am J Prev Med (2012) 1.18
Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer (2011) 1.15
Complications of screening flexible sigmoidoscopy. Gastroenterology (2002) 1.07
State-level projections of cancer-related medical care costs: 2010 to 2020. Am J Manag Care (2012) 1.06
Data sources for identifying low-income, uninsured populations: application to public health-National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 1.03
The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med (2010) 1.02
Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control (2015) 1.01
Indirect, out-of-pocket and medical costs from influenza-related illness in young children. Vaccine (2012) 1.01
Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012. Cancer Causes Control (2015) 0.98
Validation of self-reported screening mammography histories among women with and without breast cancer. Am J Epidemiol (2003) 0.97
Quality assessment of colonoscopy reporting: results from a statewide cancer screening program. Diagn Ther Endosc (2010) 0.94
Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.92
Protection of mammography screening against death from breast cancer in women aged 40-64 years. Cancer Causes Control (2007) 0.92
Worksite-based incentives and competitions to reduce tobacco use. A systematic review. Am J Prev Med (2010) 0.92
Hormone therapy and fatal breast cancer. Pharmacoepidemiol Drug Saf (2010) 0.91
Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer (2013) 0.90
Assessment of the scientific soundness of clinical performance measures: a field test of the National Committee for Quality Assurance's colorectal cancer screening measure. Arch Intern Med (2008) 0.88
Forward. The reach and health impacts of the national breast and cervical cancer early detection program. Cancer Causes Control (2015) 0.86
Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States). Cancer Causes Control (2006) 0.85
Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts. Cancer (2013) 0.84
Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus. Pharmacoeconomics (2004) 0.83
Income, employment and suicidal behavior. J Ment Health Policy Econ (2007) 0.82
Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs. Eval Program Plann (2010) 0.81
Improving colorectal cancer screening outcomes: proceedings of the second meeting of the International Colorectal Cancer Screening Network, a global quality initiative. J Med Screen (2010) 0.80
Erratum to: Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012. Cancer Causes Control (2015) 0.79
Colorectal Cancer Screening in US Seniors Ages 76-84 Years. J Community Health (2015) 0.78
Economics of immunization information systems in the United States: assessing costs and efficiency. Cost Eff Resour Alloc (2006) 0.78
Cost of Operating Population-Based Cancer Registries: Results from 4 Sub-Saharan African Countries. J Registry Manag (2019) 0.75
Early Childhood Education to Promote Health Equity: A Community Guide Economic Review. J Public Health Manag Pract (2017) 0.75
High School Completion Programs: A Community Guide Systematic Economic Review. J Public Health Manag Pract (2016) 0.75
Erratum to: The reach and health impacts of the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.75
Determinants of hospital length of stay for cervical dysplasia and cervical cancer: does managed care matter? Am J Manag Care (2004) 0.75
Erratum to: Data sources for identifying low-income, uninsured populations: application to public health-National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 0.75
Recommendations From the International Colorectal Cancer Screening Network on the Evaluation of the Cost of Screening Programs. J Public Health Manag Pract (2016) 0.75
Erratum to: Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control (2015) 0.75